Jacobs Levy Equity Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-24,500
| Closed | -$166K | – | 1083 |
|
|
2019
Q3 | $166K | Sell |
24,500
-41,390
| -63% | -$280K | ﹤0.01% | 862 |
|
|
2019
Q2 | $613K | Buy |
65,890
+14,700
| +29% | +$137K | 0.01% | 712 |
|
|
2019
Q1 | $711K | Buy |
+51,190
| New | +$711K | 0.01% | 728 |
|
|
2018
Q4 | – | Sell |
-41,908
| Closed | -$530K | – | 1100 |
|
|
2018
Q3 | $530K | Sell |
41,908
-1,800
| -4% | -$22.8K | 0.01% | 764 |
|
|
2018
Q2 | $576K | Buy |
43,708
+28,000
| +178% | +$369K | 0.01% | 771 |
|
|
2018
Q1 | $214K | Sell |
15,708
-19,100
| -55% | -$260K | ﹤0.01% | 915 |
|
|
2017
Q4 | $207K | Sell |
34,808
-84,913
| -71% | -$505K | ﹤0.01% | 902 |
|
|
2017
Q3 | $888K | Sell |
119,721
-6,299
| -5% | -$46.7K | 0.02% | 606 |
|
|
2017
Q2 | $1.18M | Buy |
126,020
+30,099
| +31% | +$282K | 0.03% | 541 |
|
|
2017
Q1 | $698K | Hold |
95,921
| – | – | 0.01% | 618 |
|
|
2016
Q4 | $710K | Sell |
95,921
-36,800
| -28% | -$272K | 0.01% | 618 |
|
|
2016
Q3 | $802K | Sell |
132,721
-17,600
| -12% | -$106K | 0.01% | 616 |
|
|
2016
Q2 | $675K | Buy |
150,321
+5,008
| +3% | +$22.5K | 0.01% | 679 |
|
|
2016
Q1 | $362K | Buy |
+145,313
| New | +$362K | 0.01% | 816 |
|
|
2015
Q1 | – | Sell |
-19,732
| Closed | -$135K | – | 909 |
|
|
2014
Q4 | $135K | Buy |
+19,732
| New | +$135K | ﹤0.01% | 767 |
|